U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. 2025 FDA CERSI Lecture Series
  1. Advancing Regulatory Science

2025 FDA CERSI Lecture Series

January 21, 2025

Examination of Patient-Reported Physical Function & Symptom Data
Yale University/Mayo Clinic CERSI

Gita Thanarajasingam, MD
Associate Professor of Medicine
Chair of Faculty Development and Recruitment
Division of Hematology
Mayo Clinic Rochester

More information coming soon.


March 13, 2025

Integrative Liquid Biopsy Approaches to Capture Minimal Residual Disease and Inform Therapeutic Decisions for Patients with Resectable Cancers
Johns Hopkins University CERSI

Valsamo Anagnostou, MD, PhD
Associate Professor of Oncology
Director, Thoracic Oncology Biorepository

More information coming soon.


May 8, 2025

Large Language Models to Support Bioequivalence Evaluation
University of California, San Francisco (UCSF) – Stanford University CERSI

Russ B. Altman, MD, PhD
Kenneth Fong Professor
Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science,
Senior Fellow at the Stanford Institute for HAI and
Professor, by courtesy, of Computer Science

More information coming soon.


July 10, 2025

Pragmatic Trials
Research Triangle CERSI

Frank W. Rockhold, PhD
Professor of Biostatistics and Bioinformatics
Duke Clinical Research Institute
Duke University Medical Center

More information coming soon.


Resources

FDA CERSI Lecture Series and CERSI Webinars

Back to Top